Description Nublexa 40mg is used to treat colon or rectal cancer that has spread to other parts of the body and is no longer responding to other treatments. It contains Regorafenib, an anti-cancer (antineoplastic) medicine that helps stop the growth and spread of cancer cells. It is also used for gastrointestinal stromal tumors (GIST) when surgery isn’t possible and treatments like imatinib and sunitinib have failed. Additionally, Nublexa 40mg is effective for liver cancer in adults who have previously been treated with sorafenib. Manufactured by Bayer Zydus Pharma Pvt Ltd, this medicine is designed to slow cancer progression and improve outcomes in advanced cancers.
Uses of Nublexa 40mg
Colon or rectal cancer that has spread after other treatments
Gastrointestinal stromal tumors (GIST) not responding to surgery or previous medications
Liver cancer in patients previously treated with sorafenib
Benefits of Nublexa 40mg
Treats advanced colon, rectal, liver, and GIST cancers
Helps slow or stop the growth of cancer cells
Reduces symptoms like bowel changes, weight loss, fatigue, and blood in stool
FDA-approved for use in adults with specific advanced cancers
How Nublexa 40mg Works Nublexa contains Regorafenib, which is a tyrosine kinase inhibitor. It blocks certain proteins that cancer cells need to grow and spread. It also prevents the formation of new blood vessels that tumors need to grow (antiangiogenic effect), ultimately stopping cancer cell growth and preventing the tumor from spreading further.
English
Deutsch
